Insider Trades
Medline CEO James M Boyle Gets 2,516,260 Voting Shares With No Economic Value
The compensation conversions account for about 82% of Boyle's reported post-transaction shares, including holdings in a family trust.
Medline (MDLN) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Insider Trades
The compensation conversions account for about 82% of Boyle's reported post-transaction shares, including holdings in a family trust.
Markets
The medical supplier lifted its organic sales growth forecast and approved a $1 billion repurchase alongside third-quarter results.
Earnings
The med-surg supplier lifted its organic sales forecast and held its profit range, while nine-month net income fell to $696 million.
SEC Filings
The affected beds made about $60 million in net sales over twelve months, and the company does not expect a material hit to 2026 results.
SEC Filings
An 8-K says the resignation takes effect December 31, 2026, and is not the result of any disagreement with the company.